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Abstract
Background: The objective of this study was to investigate neurological short-term effects of craniosacral therapy
as an ideal form of osteopathic manipulative treatment (OMT) due to the soft kinaesthetic stimulation.
Methods: Included were 30 preterm infants, with a gestational age between 25 and 33 weeks, who were admitted
to the neonatal intensive care unit of the University Hospital of Graz, Austria. The infants were randomized either
into the intervention group (IG) which received standardised craniosacral therapy, or the control group (CG) which
received standard care. To guarantee that only preterm infants with subsequent normal neurodevelopment were
included, follow up was done regularly at the corrected age (= actual age in weeks minus weeks premature) of 12
and 24 months. After 2 years 5 infants had to be excluded (IG; n = 12; CG: n = 13).
General Movements (GMs) are part of the spontaneous movement repertoire and are present from early fetal life
onwards until the end of the first half year of life. To evaluate the immediate result of such an intervention, we
selected the General Movement Assessment (GMA) as an appropriate tool. Besides the global GMA (primary
outcome) we used as detailed GMA, the General Movement Optimality Score (GMOS- secondary outcome),
based on Prechtl’s optimality concept. To analyse GMOS (secondary outcome) a linear mixed model with
fixed effects for session, time point (time point refers to the comparisons of the measurements before vs.
after each session) and intervention (IG vs. CG), random effect for individual children and a first order autoregressive
covariance structure was used for calculation of significant differences between groups and interactions. Following
interaction terms were included in the model: session*time point, session*intervention, time point*intervention and
session*time point*intervention. Exploratory post hoc analyses (interaction: session*time point*intervention) were
performed to determine group differences for all twelve measurement (before and after all 6 sessions) separately.
Results: Between groups no difference in the global GMA (primary outcome) could be observed.
The GMOS (secondary outcome) did not change from session to session (main effect session: p = 0.262) in the IG or
the CG. Furthermore no differences between IG and CG (main effect group: p = 0.361) and no interaction of
time*session could be observed (p = 0.658). Post hoc analysis showed a trend toward higher values before
(p = 0.085) and after (p = 0.075) the first session in CG compared to IG. At all other time points GMOS were
not significantly different between groups.
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Conclusion: We were able to indicate that a group of “healthy” preterm infants undergoing an intervention
with craniosacral therapy (IG) showed no significant changes in GMs compared to preterm infants without
intervention (CG). In view of the fact that the global GMA (primary outcome) showed no difference between
groups and the GMOS (detailed GMA-secondary outcome) did not deteriorate in the IG, craniosacral therapy
seems to be safe in preterm infants.
Trial registration: German Clinical Trials Register DRKS00004258.
Keywords: Infant Development, Neurologic Examination, General movements, Complementary therapies,
Preterm Infants, Neonatal intensive care unit, craniosacral therapy, osteopathic manipulative treatment (OMT)
Background
Both the management and outcome of preterm new-
borns have changed in the post surfactant era. Due to
improvements in survival rates, the focus of neonatal
care has shifted to optimizing growth, neurodevelop-
ment and long-term outcomes [1]. However, the stress-
ful environment of a neonatal intensive care unit may
compromise these vulnerable infants, in addition to the
physiologic consequences of preterm birth.
There is increasing evidence that massage therapy
and/or tactile/kinaesthetic stimulation (e.g. osteopathic
manipulative treatment (OMT)) improves i) weight gain
[2], ii) motor- and neurodevelopmental outcome [3], iii)
reduces length of hospital stay (LOS) [4], iv) increases
bonding and attachment behaviour in preterm infants
[5]. OMT is defined as “the therapeutic application of
manually guided forces by an osteopathic physician to
improve physiologic function and/or support homeosta-
sis that has been altered by somatic dysfunction” [6, 7].
The OMT techniques used in preterm infants include i)
myofascial release, ii) balanced ligamentous/membran-
ous tension, iii) indirect fluidic, and iv) v-spread [8, 9].
Overall, OMT refers to manipulative techniques ranging
from articulatory to visceral manipulation including cra-
nial osteopathy [10, 11].
Craniosacral therapy was developed out of OMT by John
Upledger, based on the research by William Garner Suther-
land [12], who hypothesized that dural tension and decrease
of cerebrospinal fluid flow could correlate with a reduction
in palpability of the cranial rhythmic impulse [13]. Further
it is assumed, that these conditions may be corrected by
gentle manipulation of the cranium and sacrum [14].
To evaluate the immediate result of an intervention on
the preterm brain, appropriate neuromotor assessment
is essential.
General Movements (GMs) are the most frequent,
complex and longest lasting pattern of the prenatal
and neonatal motor repertoire. They can be observed
from a postmenstrual age of 9 weeks to a post term
age of 5 months [15]. A systematic review of neuro-
motor assessment of preterm infants showed that the
Test of Infant Motor Performance and the General
Movement Assessment (GMA) are the only tools to ap-
propriately assess neuromotor development at term
equivalent [16]. The GMA, a tool to delineate the integ-
rity of the young nervous system, focusses on endogen-
ously generated – i.e. without sensory input – age-
specific motor patterns [17, 18]. The predictive power of
the GMA is equivalent to MRI (white matter assess-
ment) and superior to cranial ultrasound or neuro-
logical examination [19, 20].
As very low birth weight infants are extremely small and
sensitive to touch, we considered (a) craniosacral therapy
as an ideal form of OMT by soft kinaesthetic stimulation
and (b) the non-intrusive GMA as the appropriate tool to
evaluate its implications. The aim of our study was to in-
vestigate neurological short-term effects of craniosacral
therapy as a ideal form of OMT for preterm infants.
Methods
Participants
Preterm infants, with a gestational age (GA) [21] be-
tween 25 and 33 weeks who were admitted to the neo-
natal intensive care unit of the University Hospital of
Graz, Austria, were eligible. As we planned a treatment
period of 3 weeks, and most infants are discharged with
a GA of 37 weeks, the upper limit of inclusion was
33 weeks. Infants with congenital anomalies, presence
of major malformations, any abnormality in cranial
ultrasound, elevated bilirubin levels, and any need of
respiratory support (need for oxygen or mechanical
ventilation) during the study period were excluded. To
guarantee that only preterm infants with subsequent
normal neurodevelopment were included, follow up
was done regularly at the corrected age [21] of 12 and
24 months. The neurological examination was per-
formed according to Touwen [22], for neurodevelop-
mental testing the Bayley Scales of Infant Development
were applied [23]. Some infants that were initially in-
cluded were excluded later on due to signs of abnormal
neurological development. Thus the inclusion of only
neurological healthy infants was guaranteed. The ethics
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committee of the Medical University of Graz approved
the study and written parental consent was obtained prior
inclusion (20-009ex08/09). The trial was registered with
the German Clinical Trials Register DRKS00004258.
Protocol
Newborns were assigned to the intervention group
(IG) or to the control group (CG) in a 1:1 ratio using
a randomised block design with block size of 6. A se-
quentially numbered, sealed, opaque envelope con-
taining the allocation was opened by a researcher
after parental consent. Infants randomized to the IG
received a total of six interventions. Interventions
were standardised to 20 min/treatment with a fre-
quency of two intervention/ week over three weeks.
The CG did not receive the standardised intervention
or any other kind of OMT interventions during this
period (Fig. 1).
Intervention
The intervention was performed by two specialized
physiotherapists trained at the Upledger Institute
Graz, Austria, with 10 years of experience and certi-
fied as Upledger CranioSacral® Therapists. The two
physiotherapists involved in the study were trained to
use only indirect and fluidic techniques. None of the
physiotherapists were involved in the study design,
data entry or statistical analysis. Both groups received
usual care, which means – traditional (~routine) nursery
care e.g. side lying and “nesting” in an incubator and skin
to skin contact by the parents. In addition all parents, the
physicians and the GM assessors were unaware of patient
allocation except for the treating physiotherapist.
Procedure
The intervention was scheduled according to the circa-
dian rhythm of the infant (e.g. intervention was only
Fig. 1 Flowchart and study design. CST = craniosacral therapy
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started when the infant was awake and after feeding
to avoid influence of agitation due to hunger). Infants
were positioned in supine position, naked, wearing
only swaddling bands. After initial contact with the
child, by using the preferred initial touch, based on
the requirements of basal stimulation, the specialized
physiotherapist started with the evaluation of the cra-
niosacral system according to a (modified) 10 step-
program [7, 24]. The 10 step-program was modified
as follows: exploration of the cranial system (step 1),
treatment of asymmetry (step 2), evaluation of the
overlapping of the cranial bones (step 4), exploration
of the balance of the membranes of the cranial and
spinal dura mater (step 7), exploration and treatment
of the sacrum (step 8), and exploration and treatment
of the chest (step 9). After the evaluation craniosacral
therapy was initiated to achieve the greatest relaxation.
Data collection
General Movements (GMs)
GMs are part of the spontaneous movement repertoire
and are present from early fetal life onwards until the
end of the first half a year of life. GMs are complex,
occur frequently, and last long enough to be observed
properly. They involve the whole body in a variable se-
quence of arm, leg, neck, and trunk movements. They
wax and wane in intensity, force and speed, and have a
gradual beginning and end. Rotations along the axis of
the limbs and slight changes in the direction of move-
ments make them fluent and elegant and create the im-
pression of complexity and variability. If the nervous
system is impaired, GMs lose their complex and variable
character and become monotonous and poor [25]. The
GMA has been validated with a specificity of 82-99 %, a
sensitivity of 95-100 %, a negative likelihood ratio of
0.05, and a positive likelihood ratio > 51 to predict neu-
romotor development [25]
Recording and analysis of GMs
The preterm infants were videotaped twice a week: in
the IG 5 min before and after each intervention (which
means before and after OMT), and same in the CG but
without intervention.
The videos (10 min per session) were taken with the
infants lying supine in the incubator wearing only dia-
pers. Each infant was recorded 12 times, which corre-
sponds to a 2-h footage per infant.
As the GMA is dependent on the behavioural state
[26] of the infant, only infants in behavioural states 2
(i.e., eyes closed, irregular respiration, general move-
ments present) or 4 (i.e., eyes open, irregular respiration,
general movements present) were included. If an infant
was in behavioural states 1, 3, or 5 (corresponding to
quiet sleep, quiet wakefulness or crying), his/her GMs
could not be assessed. Therefore, the number of in-
fants varies slightly within the weekly assessments. All
videos were edited according to the standards of
GMA [27]. Normally, the GMs of a preterm infant
comprise the entire body and manifest themselves in
a variable sequence of arm, leg, neck and trunk
movements. They appear and cease gradually, varying
in intensity and speed. Rotations and frequent slight
variations of the direction of motion make them look
complex but smooth [15–18]. GMs are categorized as
normal (N) or abnormal. Abnormal GMs are classi-
fied into (1) “poor repertoire GMs” (PR), whereby the
sequence of movement components is monotonous;
the amplitude, speed, and intensity lack the normal
variability; (2) “cramped-synchronized GMs” (CS),
which appear rigid as they lack the usual smoothness
and fluent character; the limb and trunk muscles con-
tract almost simultaneously and relax almost simul-
taneously; and (3) “chaotic GMs” (Ch), which appear
jerky and abrupt due to their large amplitude and
high speed [15, 18].
Besides the global GMA into the categories N, CS,
PR, Ch (primary outcome) mentioned above, we
assessed as detailed GMA, the General Movement Op-
timality Score (GMOS) as secondary outcome based on
Prechtl’s optimality concept [17, 28]. The detailed
GMA (GMOS) is a further tool to assess preterm motor
movements. Thus it is a supplemental tool to define
motor optimality with the principles of GMA. The
GMOS is composed of the subscore for the sequence of
movements (maximum = 2) and three sub-component
optimality scores: (1) optimality for neck and trunk
movements (maximum = 4); (2) optimality for the
upper limb movements (maximum = 18); and (3) opti-
mality for lower limb movements (maximum = 18). A
higher score indicates a more optimal performance. For
the GMOS, the maximum composite score of 42 indi-
cates the most optimal GM performance. All GMs
judgements were done by two experts in GMA (P.B.M.,
C.E.), who were blinded to group assignment, after
completion of the 3-week structured program. In case
of disagreement on particular details the recordings in
question were re-evaluated until consensus on the final
score was achieved. GMA has been validated as a diag-
nostic tool for detecting early brain dysfunction in new-
born infants [19, 29–31]. The early identification of
individual infants at high risk remains difficult. Spittle
et al reviewed the clinometric properties of neuromotor
assessments for preterm during the first year of life
[16]. Furthermore, Bosanquet et al , Burger et al and
Noble et al showed that Prechtl’s assessment of the
quality of GMs offers the best combination of reliabil-
ity, sensitivity and specificity for predicting cerebral
palsy in the early months [19, 32, 33].
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Statistical analysis
To compare global GMA (N vs. PR vs. CS) between
groups before the first session and after the last session
Fisher’s exact test was used.
To analyze GMOS a linear mixed model with fixed ef-
fects for session, time point (time point refers to the
comparisons of the measurements before vs. after each
session) and intervention (IG vs. CG), random effect for
individual children and a first order autoregressive co-
variance structure was used for calculation of significant
differences between groups and interactions. Following
interaction terms were included in the model: session*-
time point, session*intervention, time point*intervention
and session*time point*intervention. Exploratory post
hoc analyses (linear mixed model, fixed effects: session,
time point and intervention, random effect: individual
children, interaction: session*time point*intervention)
were performed to determine group differences for all
twelve measurement (before and after all six sessions)
separately. To compare patient’s characteristics Pearson
Chi Square test and Mann Whitney u-Test was used.
To analyse inter-scorer agreement Cohen’s Kappa was
calculated. A p-value of a p < 0.05 was considered sta-
tistically significant. Statistical analysis was performed
using IBM SPSS Statistics 22 (SPSS Inc. Chicago, IL,
USA, 2013).
Results
Fifty-eight (58) newborn infants with a GA between
25-33 weeks were eligible. 28 could not be included
because they did not meet the inclusion criteria (need
for ongoing respiratory support n = 16, diagnosis of
Periventricular Leukomalacia n = 1 and Intraventricular
Haemorrhage n = 4) or the parents declined to participate
(n = 7). 30 infants (male n = 16/female n = 14) were rando-
mised to either IG (n = 15) or CG (n 15) and included in
the study. All randomised infants underwent the
three-week study protocol. All infants tolerated the
intervention well without any side effects. Overall, five
infants (IG n = 3, CG = 2) had to be excluded during
neonatal follow-up. Four infants (three in the IG and
one in the CG) developed cerebral palsy and one in-
fant in the CG developed asymmetric muscular dystonia.
Therefore, a total of 12 infants in the IG and 13 infants in
the CG were available for final analysis (Fig. 1). Partici-
pants’ characteristics are presented in Table 1.
General Movement Assessment (GMA)
Of 300 video recordings, 28 (9 %) had to be excluded,
because the behavioural state of the infants did not allow
proper assessment, and a further 4 (1 %) were excluded
due to technical problems during recording. The footage
for detailed analysis consisted of 268 assessable record-
ings and a total of 66 h recording time. The global GMA
was done off-line from video and usually took the ex-
perienced observer 3-5 min per recording (Mean:
4 min; total 17.5 h of analysis). The detailed assess-
ment (GMOS) was done offline from some video and
lasted between 20 and 30 min per recording (Mean:
23 min; total 112 h of analysis).
Primary outcome: GMA
The GMA at the beginning of the interventional
period showed that 5 infants had normal GMs (N) and
20 a poor repertoire of GMs (PR). There was no differ-
ence in global GMA between the two groups (IG: 1 N,
11 PR; CG: 4 N, 9 PR; Fisher’s exact Test P > 0.05). At
the end of the interventional period GMA were again
comparable between groups (IG: 2 N, 9 PR, 1 CS; CG:
5 N, 7 PR, 1 CS; Fisher’s exact Test P > 0.05). In each
group one infant with a PR of GMs improved to N and
one infant deteriorated from PR to CS.
Secondary outcome: GMOS
GMOS did not change from session to session (main
effect session: p = 0.262). Furthermore no differences be-
tween IG and CG (main effect group: p = 0.361) and no
interaction of session*group could be observed (inter-
action session*group: p = 0.658) (Table 2). Post hoc ana-
lysis showed a trend toward higher values before (post
hoc analysis for group differences at session 1, and time
point 1: p = 0.085) and after (post hoc analysis for group
differences at session 1, and time point 2: p = 0.075) the
first session in CG compared to IG group. At all other
time points GMOS were not significantly different be-
tween groups. (Table 3, Fig. 2).
Inter-observer agreement
For the GMA (primary outcome) the inter-scorer agree-
ment revealed a Cohen’s Kappa of 0.87; for the GMOS
(secondary outcome) Cohen’s Kappa was 0.76.







N (Male /Female) 12 (6/6) 13 (5/8) P > 0.05
GA* at birth
Median 28 30 P > 0.05
Range 25-33 27-33
Birth weight(g)
Median 1129 1170 P > 0.05
Range 690-1700 855-1760
GA* at first video recording
Median 31.5 33 P > 0.05
Range 31-35 30-34
*GA gestational age in completed weeks
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Discussion
To the best of our knowledge this is the first randomized
controlled trial using the non-intrusive GMA to evaluate
short-term effects of craniosacral therapy in preterm in-
fants who have been admitted to the neonatal intensive
care unit.
No difference in the GMA (primary outcome) during
the whole intervention period could be observed be-
tween groups.
Overall the GMOS (-secondary outcome) i) did not
change over time; ii) showed no differences between IG
and CG; iii) showed comparable courses in the two
groups; and iv) a post hoc analysis showed a trend to-
ward higher values before and after the first session in
CG, whereas at all other time points GMOS were not
significantly different between groups (Table 2, Fig. 2).
Craniosacral therapy is one of the most careful and
non-invasive therapies of OMT and one of the most
popular non-pharmacologic complementary therapies in
adult medicine [34, 35]. In addition, there are some data
available from infants and children [36, 37], reporting
positive effects of craniosacral therapy [38] and cranial
osteopathy in gastrointestinal function [39], obstructive
apnea [40] and postural asymmetry [41]. In addition,
two clinical trials have been carried out in preterm
infants while admitted to the neonatal intensive care
units. [8, 42]. Pizzolorusso et al evaluated the effect of
indirect and fluid OMT techniques on 352 infants sug-
gesting that this intervention potentially reduces LOS
(adjusted OR = 0.45; 0.26-0.74) [8]. In addition, this ob-
servational study reported a significant reduction in
number of episodes of vomiting, regurgitation, gastric
residual and enema (adjusted OR = 0.22; 0.09-0.51) [8].
Cerritelli et al investigated the effect of OMT in pre-
term infants and reported a significant reduction in
LOS. Infants who received OMT had a mean LOS of
26.1 ± 16.4 days compared to 31.3 ± 20.2 days in the
control group (p < 0.03) [37, 43].
Table 2 Effect of group (Intervention group, Control Group), session (six different sessions), time point (before and after each
session) and interaction terms on General Movement Optimality Score. (Linear mixed model, Type III Tests of Fixed Effects)
Source Numerator df Denominator df F P
Intercept 1 30.899 336.764 0.000
Group 1 30.899 0.859 0.361
Session 5 192.761 1.308 0.262
Time point 1 235.000 1.691 0.195
Group * Session 5 192.761 0.655 0.658
Group * Time point 1 235.000 2.151 0.144
Session * Time point 5 205.358 2.042 0.074
Group * Session * Time point 5 205.358 0.501 0.775
Table 3 Study outcomes
Intervention Group (IG) Control Group (CG) sign.
PRIMARY OUTCOME
GMA 1 N, 11 PR; 4 N, 9 PR; Fisher’s exact Test
before the 1st session P > 0.05
Global GMA 2 N, 9 PR, 1 CS; 5 N, 7 PR, 1 CS; Fisher’s exact Test
after the last session Assessment P > 0.05
SECONDARY OUTCOME
GMOS 23 (21-31) 32 (28-38) P* = 0.085
before the 1st session
Median (Interquartile Range)
GMOS 19 (13.5-33.3) 20 (12,5-38.5) P* = 0.722
after the last session
Median (Interquartile Range)
P* values from exploratory post hoc analyses followed linear mixed model with a fixed effect for session, time point (before vs. after session) and intervention (IG vs. CG)
N normal General Movements
PR poor repertoire General Movements
CS cramped-synchronized General Movements
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However, the effects of OMT and craniosacral
therapy in preterm infants are not fully understood
[8, 10, 37, 38]. There are several hypotheses including i)
anti-inflammatory effects, ii) increases in the opioid reac-
tions, or iii) effect on the autonomic nervous system.
Narendran et al reported higher level of cortisol, al-
bumin, IL-8 and IL-1β in preterm infants [37, 44],
suggesting an increased level of systemic inflamma-
tion. A recent study demonstrated that osteopathic
treatment could reduce the inflammatory process act-
ing mainly on anti-inflammatory factors [37, 45]. In
addition, Degenhardt et al suggested that OMT could
have a role in increasing the opioid reaction [37, 46].
However, this hypothesis has some intrinsic limita-
tions in terms of the sample used, i.e. no infants were
osteopathically treated, and in translating in vitro
findings into in vivo mechanisms. Longin et al [37, 47] re-
ported that the gestational age of newborn infants is cor-
related with changes in heart rate variability (HRV). From
the osteopathic perspective, changes in the HRV were re-
corded after the application of myofascial release tech-
niques [37, 48, 49]. For this reason, the application of
OMT could balance the sympathetic and parasympathetic
inputs, creating an improvement of newborns clinical con-
dition [8, 10].
GMs can be first seen in foetuses as young as
9 weeks post-menstrual age. Initially they are called
foetal GMs and can be investigated during ultrasound
recordings. Up to term age birth they become pre-
term GMs [15]. GMA is a new technique, which is
based on the investigation of spontaneous move-
ments, introduced by Prechtl et al [16–20]. Using the
global GMA (primary outcome), PR GMs were ob-
served most frequently in the present study, which is
similar to previously reported findings [50]. A high
incidence of PR GM’s is known in preterm infants
and does not necessarily result in neurodevelopmental
deficits. Because of that, the predictive value of the
quality of GMs soon after birth is largely unknown
and the predictive power of PR GMs is low [15, 46, 51].
On the other hand, PR GMs clearly demonstrate that the
infant’s nervous system is not in an optimal condition at
the time of recording.
Two of the infants (1 IG and 1CG) showed CS
GMs during the study period, but developed normally
over time. CS GMs, the most severe motor abnormal-
ity, has been found to be predictive of severe neuro-
logical impairment but only if they are consistent
over time or predominant from preterm birth to
5 months post term age. If CS GMs appear transient
their predictive value is low and normal development
will follow in most cases [52]. The GMOS (detailed
GMA = secondary outcome) did not change over time
(p = 0.262) in both the IG and the CG,
Strengths of the study
We would like to emphasize that i) only infants with nor-
mal and adequate neurodevelopmental evaluation remained
within the study groups; therefore, all included infants (in
both groups) showed adequate normal neurodevelopment
at the age of two years, ii) this was a randomised trial, iii)
we used an established assessment instrument (general (pri-
mary outcome) and detailed GMA (secondary outcome)
and iv) the assessors of the GMs were completely blinded
with respect to group assignment. In addition, there was no
difference in terms of their diseases of prematurity, the
diagnosis of respiratory distress or bronchopulmonary dys-
plasia [53] or the duration of mechanical ventilation.
Fig. 2 Secondary outcome: Course of GMOS in Intervention Group (IG) and Control Group (CG). GMOS did not change from session to session
(main effect session: p =0.262) in either group. x-axis: 6 episodes of video assessment during study period of 3 weeks (B = Before Intervention, A
= After Intervention). y-axis: GMOS Score. The symbols represent medians and the variations represent the interquartile (P25, P75)
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Weaknesses of the study
We only included a small sample size, which is a
limitation of the study. We planned enrollment of 12
subjects per group, as proposed by Julious [54] and
Billingham et al [55]. An additional 20 % (total of 15)
was included for each treatment arm, anticipating
subject withdrawal or other unforeseen postenroll-
ment exclusions from the study [54, 55]. Based on
our results we conducted power analysis and sample
size calculation. Our study has a power of 22 % to
detect an interaction of intervention*time. In a future
trial using the same approach, 57 children in each
group would have to be included to detect a signifi-
cant treatment effect (interaction of intervention*time)
with a power of 80 %.
The following questions arise: Are two interventions
per week enough to see any significant effects? Would
the results be different by using another kind of OMT?
Should further studies include a control group with
“touch” and “presence” of the therapist?
Nevertheless, the results of the present study underline
the fact, that using craniosacral therapy in preterm in-
fants is safe, as there was no deterioration of neurodeve-
lopmental results in IG.
Conclusion
In conclusion, we were able to show that a group of
“healthy” preterm infants undergoing an intervention
with craniosacral therapy (IG) showed no significant
changes in global (primary outcome) and detailed GMA
(secondary outcome) during an observation period of
3 weeks compared to infants without intervention (CG).
In view of the fact that the GMOS (secondary outcome)
did not deteriorate in the IG, craniosacral therapy seems
to be safe in preterm infants.
Currently the treatment of preterm infants with any
kind of OMT should be limited to clinical trials. Studies
evaluating short- and long-term effects are urgently
needed. Furthermore, future studies should include a
control for touch and presence of the therapist.
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